Literature DB >> 28659227

The role of genetic liability in the association of urbanicity at birth and during upbringing with schizophrenia in Denmark.

D Paksarian1, B B Trabjerg2, K R Merikangas1, O Mors3, A D Børglum3, D M Hougaard4, J J McGrath2, C B Pedersen2, P B Mortensen2, E Agerbo2.   

Abstract

BACKGROUND: Studies have indicated that the association of urbanicity at birth and during upbringing with schizophrenia may be driven by familial factors such as genetic liability. We used a population-based nested case-control study to assess whether polygenic risk score (PRS) for schizophrenia was associated with urbanicity at birth and at age 15, and to assess whether PRS and parental history of mental disorder together explained the association between urbanicity and schizophrenia.
METHODS: Data were drawn from Danish population registries. Cases born since 1981 and diagnosed with schizophrenia between 1994 and 2009 were matched to controls with the same sex and birthdate (1549 pairs). Genome-wide data were obtained from the Danish Neonatal Screening Biobank and PRSs were calculated based on results of a separate, large meta-analysis.
RESULTS: Those with higher PRS were more likely reside in the capital compared with rural areas at age 15 [odds ratio (OR) 1.19, 95% confidence interval (CI) 1.01-1.40], but not at birth (OR 1.09, 95% CI 0.95-1.26). Adjustment for PRS produced almost no change in relative risks of schizophrenia associated with urbanicity at birth, but slightly attenuated those for urban residence at age 15. Additional adjustment for parental history led to slight attenuation of relative risks for urbanicity at birth [incidence rate ratio (IRR) for birth in capital = 1.54, 95% CI 1.18-2.02; overall p = 0.016] and further attenuation of relative risks for urbanicity at age 15 (IRR for residence in capital = 1.32, 95% CI 0.97-1.78; overall p = 0.148).
CONCLUSIONS: While results regarding urbanicity during upbringing were somewhat equivocal, genetic liability as measured here does not appear to explain the association between urbanicity at birth and schizophrenia.

Entities:  

Keywords:  Epidemiology; polygenic risk score; schizophrenia; selective migration; urbanicity

Mesh:

Year:  2017        PMID: 28659227      PMCID: PMC6361630          DOI: 10.1017/S0033291717001696

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  47 in total

1.  Genetic epidemiology of schizophrenia: phenotypes, risk factors, and reproductive behavior.

Authors:  Assen V Jablensky; Luba V Kalaydjieva
Journal:  Am J Psychiatry       Date:  2003-03       Impact factor: 18.112

2.  The drift hypothesis and socioeconomic differentials in schizophrenia.

Authors:  R LAPOUSE; M A MONK; M TERRIS
Journal:  Am J Public Health Nations Health       Date:  1956-08

3.  The schizophrenia envirome.

Authors:  Jim van Os; Lydia Krabbendam; Inez Myin-Germeys; Philippe Delespaul
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

4.  Family history, place and season of birth as risk factors for schizophrenia in Denmark: a replication and reanalysis.

Authors:  C B Pedersen; P B Mortensen
Journal:  Br J Psychiatry       Date:  2001-07       Impact factor: 9.319

5.  Decreasing seasonal variation of births in schizophrenia.

Authors:  J M Suvisaari; J K Haukka; A J Tanskanen; J K Lönnqvist
Journal:  Psychol Med       Date:  2000-03       Impact factor: 7.723

6.  Choice of residential location: chance, family influences, or genes?

Authors:  John B Whitfield; Gu Zhu; Andrew C Heath; Nicholas G Martin
Journal:  Twin Res Hum Genet       Date:  2005-02       Impact factor: 1.587

7.  Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk.

Authors:  C B Pedersen; P B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2001-11

8.  Are the cause(s) responsible for urban-rural differences in schizophrenia risk rooted in families or in individuals?

Authors:  Carsten B Pedersen; Preben Bo Mortensen
Journal:  Am J Epidemiol       Date:  2006-05-04       Impact factor: 4.897

9.  Effects of family history and place and season of birth on the risk of schizophrenia.

Authors:  P B Mortensen; C B Pedersen; T Westergaard; J Wohlfahrt; H Ewald; O Mors; P K Andersen; M Melbye
Journal:  N Engl J Med       Date:  1999-02-25       Impact factor: 91.245

10.  Schizophrenia and city life.

Authors:  G Lewis; A David; S Andréasson; P Allebeck
Journal:  Lancet       Date:  1992-07-18       Impact factor: 79.321

View more
  13 in total

1.  Association of Urbanicity With Psychosis in Low- and Middle-Income Countries.

Authors:  Jordan E DeVylder; Ian Kelleher; Monique Lalane; Hans Oh; Bruce G Link; Ai Koyanagi
Journal:  JAMA Psychiatry       Date:  2018-07-01       Impact factor: 21.596

Review 2.  Polygenic Risk Scores in Clinical Psychology: Bridging Genomic Risk to Individual Differences.

Authors:  Ryan Bogdan; David A A Baranger; Arpana Agrawal
Journal:  Annu Rev Clin Psychol       Date:  2018-05-07       Impact factor: 18.561

3.  Association Between Population Density and Genetic Risk for Schizophrenia.

Authors:  Lucía Colodro-Conde; Baptiste Couvy-Duchesne; John B Whitfield; Fabian Streit; Scott Gordon; Kathryn E Kemper; Loic Yengo; Zhili Zheng; Maciej Trzaskowski; Eveline L de Zeeuw; Michel G Nivard; Marjolijn Das; Rachel E Neale; Stuart MacGregor; Catherine M Olsen; David C Whiteman; Dorret I Boomsma; Jian Yang; Marcella Rietschel; John J McGrath; Sarah E Medland; Nicholas G Martin
Journal:  JAMA Psychiatry       Date:  2018-09-01       Impact factor: 21.596

4.  Exploring the relationship between polygenic risk for cannabis use, peer cannabis use and the longitudinal course of cannabis involvement.

Authors:  Emma C Johnson; Rebecca Tillman; Fazil Aliev; Jacquelyn L Meyers; Jessica E Salvatore; Andrey P Anokhin; Danielle M Dick; Howard J Edenberg; John R Kramer; Samuel Kuperman; Vivia V McCutcheon; John I Nurnberger; Bernice Porjesz; Marc A Schuckit; Jay Tischfield; Kathleen K Bucholz; Arpana Agrawal
Journal:  Addiction       Date:  2019-01-01       Impact factor: 7.256

5.  Spatial fine-mapping for gene-by-environment effects identifies risk hot spots for schizophrenia.

Authors:  Chun Chieh Fan; John J McGrath; Vivek Appadurai; Alfonso Buil; Michael J Gandal; Andrew J Schork; Preben Bo Mortensen; Esben Agerbo; Sandy A Geschwind; Daniel Geschwind; Thomas Werge; Wesley K Thompson; Carsten Bøcker Pedersen
Journal:  Nat Commun       Date:  2018-12-13       Impact factor: 14.919

Review 6.  Psychosis and urbanicity: a review of the recent literature from epidemiology to neurourbanism.

Authors:  Anne-Kathrin J Fett; Imke L J Lemmers-Jansen; Lydia Krabbendam
Journal:  Curr Opin Psychiatry       Date:  2019-05       Impact factor: 4.741

7.  Schizophrenia is Associated With an Aberrant Immune Response to Epstein-Barr Virus.

Authors:  Faith Dickerson; Lorraine Jones-Brando; Glen Ford; Giulio Genovese; Cassie Stallings; Andrea Origoni; Colm O'Dushlaine; Emily Katsafanas; Kevin Sweeney; Sunil Khushalani; Robert Yolken
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

8.  Neighborhood Characteristics at Birth and Positive and Negative Psychotic Symptoms in Adolescence: Findings From the ALSPAC Birth Cohort.

Authors:  Francesca Solmi; Glyn Lewis; Stanley Zammit; James B Kirkbride
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

9.  Association between genetic and socioenvironmental risk for schizophrenia during upbringing in a UK longitudinal cohort.

Authors:  J B Newbury; L Arseneault; A Caspi; T E Moffitt; C L Odgers; D W Belsky; K Sugden; B Williams; A P Ambler; T Matthews; H L Fisher
Journal:  Psychol Med       Date:  2020-09-25       Impact factor: 10.592

10.  Assessment of the Role of IQ in Associations Between Population Density and Deprivation and Nonaffective Psychosis.

Authors:  Gemma Lewis; Jennifer Dykxhoorn; Håkan Karlsson; Golam M Khandaker; Glyn Lewis; Christina Dalman; James B Kirkbride
Journal:  JAMA Psychiatry       Date:  2020-07-01       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.